Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    HLA-DQB1
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
Condition: Atrophic Glossitis, Burning Mouth Syndrome
Intervention: Dietary Supplement: Supplementation of vitamin B complex, C, B12, folic acid, Iron and Zinic
2 Recruiting Chronic Infection With Tropheryma Whipplei: Risk Factors Related to the Host
Condition: Whipple Infection
Intervention: Biological: Blood Sample
3 Completed NGS for HLA Typing of Donors and récipients oh Hematopoietic Stem Cells
Condition: Next Generation Sequencing for HLA Typing
4 Completed Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025
Conditions: HIV Infection;   Hepatitis B
5 Recruiting Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: busulfan;   Drug: melphalan;   Drug: fludarabine;   Biological: anti-thymocyte globulin (ATG);   Procedure: a T cell depleted stem cell transplant

Indicates status has not been verified in more than two years